Nordic Nanovector ASA (DE:8NN) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Thor Medical ASA is set to raise approximately NOK 150 million through a private placement and a retail offering, aiming to finance its AlphaOne plant for radioisotope production. The offerings, targeting both Norwegian and international investors, will be settled in tranches with a fixed subscription price of NOK 2.50 per share. The funds will support the plant’s development, ensuring cash-positive operations and meeting existing and future sales agreements.
For further insights into DE:8NN stock, check out TipRanks’ Stock Analysis page.